Android app Apple app link

Kiniksa Pharmaceuticals, Ltd. (KNSA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$44.45
Day's range
$46.86

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/30/2026 Goldman Sachs Paul Choi $90.00 $80.92   11.22%
07/29/2026 Canaccord Genuity Edward Nash $98.00 $79.44   23.36%
07/23/2026 Goldman Sachs Paul Choi $75.00 $62.44   20.12%
04/28/2026 Jefferies Roger Song $71.00 $53.80   31.97%
01/13/2026 Wedbush David Nierengarten $50.00 $39.65   26.1%
10/29/2024 Evercore ISI Liisa Bayko $35.00 $23.27   50.44%
09/12/2024 Jefferies Roger Song $40.00 $24.49   63.33%
05/03/2024 Wells Fargo Eva Fortea Verdejo $34.00 $19.38   75.44%

Kiniksa Pharmaceuticals International Plc. FAQ's

Kiniksa Pharmaceuticals International Plc. has been rated by research analysts at Goldman Sachs, Wedbush, Canaccord Genuity, Wells Fargo, Jefferies, Evercore ISI in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.